RY

170.17

-0.25%↓

TD

94.1

-0.13%↓

BMO

130.69

+0.63%↑

BNS

74.06

+0.47%↑

CM

90.98

+0.36%↑

RY

170.17

-0.25%↓

TD

94.1

-0.13%↓

BMO

130.69

+0.63%↑

BNS

74.06

+0.47%↑

CM

90.98

+0.36%↑

RY

170.17

-0.25%↓

TD

94.1

-0.13%↓

BMO

130.69

+0.63%↑

BNS

74.06

+0.47%↑

CM

90.98

+0.36%↑

RY

170.17

-0.25%↓

TD

94.1

-0.13%↓

BMO

130.69

+0.63%↑

BNS

74.06

+0.47%↑

CM

90.98

+0.36%↑

RY

170.17

-0.25%↓

TD

94.1

-0.13%↓

BMO

130.69

+0.63%↑

BNS

74.06

+0.47%↑

CM

90.98

+0.36%↑

Search

Hercules Capital Inc

Open

SectorFinance

18.8 -0.11

Overview

Share price change

24h

Current

Min

18.67

Max

18.85

Key metrics

By Trading Economics

Income

61M

119M

Sales

89M

169M

P/E

Sector Avg

10.764

25.743

Dividend yield

8.56

Profit margin

70.164

Employees

100

EBITDA

18M

120M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+6.48% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

8.56%

3.67%

Market Stats

By TradingEconomics

Market Cap

139M

3.4B

Previous open

18.91

Previous close

18.8

News Sentiment

By Acuity

50%

50%

168 / 526 Ranking in Finance

Technical Score

By Trading Central

Confidence

Neutral Evidence

Hercules Capital Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

31 gru 2025, 22:20 UTC

Major Market Movers

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 gru 2025, 17:31 UTC

Major Market Movers

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 gru 2025, 16:30 UTC

Major Market Movers

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 gru 2025, 15:19 UTC

Major Market Movers

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 gru 2025, 15:17 UTC

Major Market Movers

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 gru 2025, 14:37 UTC

Major Market Movers

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

1 sty 2026, 23:35 UTC

Market Talk

Gold Rises Amid Geopolitical Risks -- Market Talk

1 sty 2026, 21:29 UTC

Acquisitions, Mergers, Takeovers

BlueScope: Transaction Completed on Terms Agreed When Deal Announced on Nov 13

1 sty 2026, 21:29 UTC

Acquisitions, Mergers, Takeovers

BlueScope Sold Stake in JV to Tata Steel

1 sty 2026, 21:28 UTC

Acquisitions, Mergers, Takeovers

BlueScope Steel Says Sale of Stake in Tata BlueScope Steel Completed on Dec 31

1 sty 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

1 sty 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 gru 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 gru 2025, 21:13 UTC

Acquisitions, Mergers, Takeovers

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 gru 2025, 20:40 UTC

Market Talk

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 gru 2025, 20:22 UTC

Market Talk

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 gru 2025, 19:50 UTC

Market Talk

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 gru 2025, 19:31 UTC

Market Talk

Precious Metals Cap Off Record Runs -- Market Talk

31 gru 2025, 18:50 UTC

Market Talk

Global Equities Roundup: Market Talk

31 gru 2025, 18:50 UTC

Market Talk

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 gru 2025, 17:17 UTC

Market Talk

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 gru 2025, 17:16 UTC

Major Market Movers

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 gru 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

31 gru 2025, 17:00 UTC

Acquisitions, Mergers, Takeovers

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 gru 2025, 15:57 UTC

Acquisitions, Mergers, Takeovers

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 gru 2025, 15:54 UTC

Market Talk

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 gru 2025, 15:02 UTC

Major Market Movers

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 gru 2025, 14:40 UTC

Acquisitions, Mergers, Takeovers

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 gru 2025, 14:20 UTC

Market Talk

Crude Futures On Track to End the Year With Losses -- Market Talk

31 gru 2025, 13:46 UTC

Market Talk

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

Peer Comparison

Price change

Hercules Capital Inc Forecast

Price Target

By TipRanks

6.48% upside

12 Months Forecast

Average 20.04 USD  6.48%

High 24 USD

Low 18 USD

Based on 7 Wall Street analysts offering 12 month price targets forHercules Capital Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

7 ratings

6

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

17.41 / 17.93Support & Resistance

Short Term

Neutral Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

168 / 526 Ranking in Finance

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Hercules Capital Inc

Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable
help-icon Live chat